TBMC underwent massive shareholder redemptions (2.05M shares redeemed at $11.70/share) and complete CEO turnover while suffering an $8.6M earnings swing and 85% asset decline.
This SPAC appears to be in severe distress with shareholders fleeing en masse, forcing liquidation of nearly half the trust account and creating a negative equity position of $15.9M. The complete management overhaul with Yosef Eichorn replacing Arie Rabinowitz as CEO, combined with extension of the business combination deadline to March 30, 2026, suggests the company is struggling to complete its acquisition mission and may be approaching liquidation.
The financial picture is catastrophic - net income plummeted from $278K to negative $8.3M, total assets collapsed 85% from $27.7M to $4.3M primarily due to the $24M trust account redemption, and stockholders equity deteriorated to negative $15.9M. Current liabilities surged 177% to $14.2M while current assets fell 76% to just $213K, creating severe liquidity stress. This represents a company burning through capital with minimal assets remaining and mounting obligations, typical of a failing SPAC approaching its liquidation deadline.
Net income declined 3085.7% — review whether driven by operations, interest costs, or non-recurring items.
Current liabilities surged 177.2% — significant near-term obligations; verify ability to meet short-term debt.
Equity declined sharply — large losses, buybacks, or write-downs reducing book value significantly.
Liabilities grew 126.1% — significant increase in debt or obligations, assess impact on financial flexibility.
Total assets contracted 84.5% — asset sales, write-downs, or balance sheet optimization underway.
Current assets declined 76.4% — monitor working capital adequacy and short-term liquidity.
Operating cash flow fell 63.7% — earnings quality concerns; investigate working capital changes and non-cash items.
Cash position surged 33.7% — strong cash generation or capital raise providing significant financial cushion.
Operating profitability softening — costs rising faster than revenue, watch for margin recovery plan.
See what changed in your portfolio's filings
500+ US-listed companies analyzed. Language delta, financial analysis, instant signal scoring.
Try Tracenotes free →